Bray Capital Advisors
Annual return '25
+19.4%
SPY '25
+17.7%
Alpha
+1.7ptsvs SPY
Invested
$292.6M
Holdings
29
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 93%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$DCTH
DELCATH SYS INC
Held since at least Q1 2024
11.7%
02
$CYTK
CYTOKINETICS INC
Held since at least Q1 2024
7.8%
03
$FENC
FENNEC PHARMACEUTICALS INC
Held since at least Q1 2024
6.9%
04
$VSTM
VERASTEM INC
Held since at least Q1 2024
6.0%
05
$RZLT
REZOLUTE INC
Held since at least Q1 2024
6.0%
06
$XERS
XERIS BIOPHARMA HOLDINGS INC
Held since at least Q1 2024
5.2%
07
$SVRA
SAVARA INC
Held since at least Q1 2024
5.0%
08
$MDWD
MEDIWOUND LTD
Held since at least Q1 2024
4.8%
09
$VRDN
VIRIDIAN THERAPEUTICS INC
Held since at least Q1 2024
4.6%
10
$CGON
CG ONCOLOGY INC
Held since at least Q1 2024
4.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:22 UTC.